Insider · CIK 0001818267
Webster Bailey
Files at PVCT (PROVECTUS BIOPHARMACEUTICALS, INC.). First filing -, latest -.
Webster Bailey files SEC Form 4 as director at PVCT (PROVECTUS BIOPHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Webster Bailey has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | PVCT PROVECTUS BIOPHARMACEUTICALS, INC. | AGrant or award Series D-1 Convertible Preferred Stockderivative | +48,917 | $0.00 | $0 | 207,535 | Jun 30, 2026 |
| Dec 2, 2024 | PVCT PROVECTUS BIOPHARMACEUTICALS, INC. | AGrant or award Stock Options (Right to Buy)derivative | +775,082 | $0.00 | $0 | 775,082 | Dec 4, 2024 |
Questions about Webster Bailey
Answered from the filings on this page, as of the latest one.
Is Webster Bailey buying or selling?
Webster Bailey has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Webster Bailey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Webster Bailey has 0.
Where does Webster Bailey file Form 4?
Webster Bailey has filed Form 4 at PVCT (PROVECTUS BIOPHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.